Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Repligen Corp (NASDAQ:RGEN)

24.24
Delayed Data
As of May 27
 +0.57 / +2.41%
Today’s Change
20.07
Today|||52-Week Range
42.48
-14.32%
Year-to-Date
No recent news for Repligen Corp.

Today’s Trading

Previous close23.67
Today’s open23.61
Day’s range23.33 - 24.28
Volume141,411
Average volume (3 months)328,587
Market cap$815.4M
Dividend yield--
Data as of 3:59pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)+12.00%
Earnings growth (this year)+67.86%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+31.45%
P/E ratio101.3
Price/Sales11.37
Price/Book6.51

Competitors

 Today’s
change
Today’s
% change
MACKMerrimack Pharmaceut...-0.23-3.52%
MGNXMacroGenics Inc+0.55+2.30%
LCILannett Company Inc+0.78+3.40%
ADROAduro Biotech Inc+0.34+2.99%
Data as of 4:01pm ET, 05/27/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)$0.13
Annual revenue (last year)$83.5M
Annual profit (last year)$9.3M
Net profit margin11.19%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Tony J. Hunt
Vice President-
Global Operations
Steve Curran
Corporate headquarters
Waltham, Massachusetts

Forecasts

Partner Offers

Search for Jobs